Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $701 - $851
-58 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$13.25 - $15.13 $23,532 - $26,870
-1,776 Reduced 96.84%
58 $1,000
Q2 2021

Aug 16, 2021

SELL
$12.97 - $16.15 $9,935 - $12,370
-766 Reduced 29.46%
1,834 $27,000
Q1 2021

May 13, 2021

SELL
$13.59 - $18.54 $7,719 - $10,530
-568 Reduced 17.93%
2,600 $36,000
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $45,302 - $59,368
3,168 New
3,168 $60,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $11.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Enterprise Financial Services Corp Portfolio

Follow Enterprise Financial Services Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Financial Services Corp with notifications on news.